Report #2826476

Received Feb 17, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: Age unknown
State: LA
Recovered: Unknown
Vaccinated: —
Onset: —
Days to onset: —
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
VARZOS	ZOSTER (SHINGRIX)	GLAXOSMITHKLINE BIOLOGICALS	2	UNK	—

Symptoms (1)

Incomplete course of vaccination

Symptom narrative

the patient had not received the 2nd dose yet.; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete course of vaccination in a elderly female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix (1st dose received in 2020 batch number 5SB37 and expiry date 19-jun-22). On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: the patient had not received the 2nd dose yet.). The outcome of the incomplete course of vaccination was unknown. Additional Information: GSK Receipt Date: 12-FEB-2025 The patient received one dose of Shingrix. VAERS details reported for 1st dose of Shingrix. The reporter asked question did they need to restart it? Reporter mentioned that at the time of reporting, the patient had not received the 2nd dose yet, which led incomplete course of vaccination. The reporter consented to follow up.